🔎 Trials Near Me

Utama › Karsinoma Sel Skuamosa Kepala dan Leher › Ohio › Columbus

Kajian klinikal Karsinoma Sel Skuamosa Kepala dan Leher di Columbus, OH

20 kajian untuk Karsinoma Sel Skuamosa Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Mengambil pesertaFasa 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06992427

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Mengambil pesertaFasa 1
  • ALX Center 10, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07085091

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Mengambil pesertaFasa 3
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07276399

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • Research Site, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06535607

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06657222

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Mengambil pesertaKajian pemerhatian
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 2
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06769698

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Mengambil pesertaFasa 2/3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT05985655

SMP-3124LP in Adults With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06526819

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT03526835

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Mengambil pesertaFasa 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT04754321

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Stefanie Spielman Comprehensive Breast Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06064877

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT06323460

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Mengambil peserta
  • Ohio State University Medical Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT01473784

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Dis 2025 · NCT06943521

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Mengambil pesertaFasa 1/2
  • The Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2025 · NCT06682793

Kajian Karsinoma Sel Skuamosa Kepala dan Leher di bandar lain

Kajian lain di Columbus

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.